12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

• Embecta (NASDAQ:EMBC) shares increased by 37.7% to $14.14 during Thursday's regular session. The company's market cap stands at $814.1 million. As per the press release, Q2 earnings came out today.
• Seres Therapeutics (NASDAQ:MCRB) shares moved upwards by 36.28% to $1.02. The market value of their outstanding shares is at $154.2 million. The company's, Q1 earnings came out yesterday.
• G1 Therapeutics (NASDAQ:GTHX) shares rose 35.08% to $5.79. The company's market cap stands at $302.9 million.
• Vaccinex (NASDAQ:VCNX) shares rose 31.75% to $7.51. The market value of their outstanding shares is at $11.8 million.
• Zai Lab (NASDAQ:ZLAB) stock increased by 25.28% to $20.76. The company's market cap stands at $2.0 billion. As per the press release, Q1 earnings came out yesterday.
• CareCloud (NASDAQ:CCLD) shares moved upwards by 24.07% to $1.34. The market value of their outstanding shares is at $21.5 million.

Losers

• Tivic Health Systems (NASDAQ:TIVC) stock decreased by 58.7% to $0.55 during Thursday's regular session.
• CytomX Therapeutics (NASDAQ:CTMX) stock fell 41.89% to $2.44. The company's market cap stands at $165.9 million. As per the news, the Q1 earnings report came out yesterday.
• RAPT Therapeutics (NASDAQ:RAPT) stock fell 41.11% to $4.7. The market value of their outstanding shares is at $163.5 million. As per the news, the Q1 earnings report came out today.
• Syra Health (NASDAQ:SYRA) stock fell 35.56% to $1.38. The market value of their outstanding shares is at $9.1 million. As per the press release, Q1 earnings came out today.
• NeuroPace (NASDAQ:NPCE) stock decreased by 31.51% to $8.63. The market value of their outstanding shares is at $247.8 million. The company's, Q1 earnings came out yesterday.
• Reviva Pharmaceuticals (NASDAQ:RVPH) stock decreased by 22.35% to $2.19. The market value of their outstanding shares is at $61.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.